Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo‐controlled study

AIMS: Five‐α reductase inhibitor (5ARI) therapy has been associated with sexual dysfunction in some patients. This study assessed the impact of a fixed‐dose combination of the 5ARI dutasteride 0.5 mg and the α(1)‐adrenoceptor antagonist tamsulosin 0.4 mg (DUT‐TAM FDC) on Men's Sexual Health Que...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Raymond C., Roehrborn, Claus G., Manyak, Michael J., Palacios‐Moreno, Juan Manuel, Wilson, Timothy H., Lulic, Zrinka, Giuliano, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767409/
https://www.ncbi.nlm.nih.gov/pubmed/30317693
http://dx.doi.org/10.1111/ijcp.13282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767409/
https://www.ncbi.nlm.nih.gov/pubmed/30317693
http://dx.doi.org/10.1111/ijcp.13282

Ejemplares similares